Additionally, we examined the molecular mechanisms of metastasis and examined therapeutic strategies to overcome tumor growth and metastasis in SMARCB1-deficient BLCA driven by STAT3 pathway upregulation. Here, STAT3 is linked to bladder transitional cell carcinoma.